Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Artiva Biotherapeutics, Inc. (ARTV) had Debt to Capital Ratio of 0.00 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-20.31M |
|
-- |
|
-- |
|
$22.17M |
|
$-22.17M |
|
$1.86M |
|
$-20.31M |
|
$-20.31M |
|
$-20.31M |
|
$-20.31M |
|
$-20.31M |
|
$-20.31M |
|
$-22.17M |
|
$-21.54M |
|
24.34M |
|
24.34M |
|
$-0.83 |
|
$-0.83 |
|
| Balance Sheet Financials | |
$170.00M |
|
$7.06M |
|
$21.26M |
|
$191.26M |
|
$12.20M |
|
$0.01M |
|
$10.28M |
|
$22.48M |
|
$168.78M |
|
$168.78M |
|
$168.78M |
|
24.36M |
|
| Cash Flow Statement Financials | |
$-19.84M |
|
$9.97M |
|
$0.24M |
|
$40.49M |
|
$30.86M |
|
$-9.63M |
|
$2.05M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.93 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.00 |
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-20.35M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-12.03% |
|
-12.03% |
|
-10.62% |
|
-12.03% |
|
$6.93 |
|
$-0.84 |
|
$-0.82 |
|